UTRS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 01:18):

Stats
今日成交量	26 100.00
平均成交量	2 595.00
市值	8 879.00
EPS	$0 ( 2024-05-03 )
下一个收益日期	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-01	Cohen Daniel	Buy	0	Common Stock
2023-02-09	New Enterprise Associates 13 Lp	Buy	24 437 927	Common Stock
2023-02-09	Accelmed Partners Ii L.p.	Sell	0	Common Stock
2023-02-09	Geiger Uri	Buy	0	Common Stock
2023-01-02	Usen Todd	Buy	0

INSIDER POWER
100.00
Last 92 transactions
Buy: 38 540 336 \| Sell: 1 194 556

Minerva Surgical, Inc. 相关性

10 最正相关
MOTS	0.918
LGVN	0.914
CYTO	0.912
PCSA	0.911
CNEY	0.909
KXIN	0.908
DXYN	0.907
CVAC	0.907
CNSP	0.905
BCAN	0.898

10 最负相关
STEP	-0.915
AMRB	-0.912
AGFS	-0.91
SYNH	-0.887
RNLC	-0.886
LWAC	-0.884
SGII	-0.881
CSWI	-0.879
BRIVU	-0.874
IMPP	-0.874

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Minerva Surgical, Inc. 财务报表

Annual	2022
营收:	$50.29M
毛利润:	$27.24M (54.17 %)
EPS:	$-23.68

FY	2022
营收:	$50.29M
毛利润:	$27.24M (54.17 %)
EPS:	$-23.68

FY	2021
营收:	$52.10M
毛利润:	$30.52M (58.58 %)
EPS:	$-1.158

FY	2020
营收:	$37.77M
毛利润:	$19.12M (50.62 %)
EPS:	$-1.090

Financial Reports:

No articles found.

Minerva Surgical, Inc.

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.